Integra Donates over $35,000 to Support Groundbreaking Breast Cancer Research

Breast cancer is one of the most common forms of cancer facing women worldwide. To help fight this disease, Integra launched PIPETGIRL - a limited edition of the PIPETBOY acu 2 pipette controller - in 2015 to support internationally renowned research institutes dedicated to finding a cure for breast cancer, donating €10/US$15 from each sale. A number of research institutes have benefitted since the scheme’s beginning and, as this initiative has now come to a close, Integra is delighted to have awarded the last donation of €15,000 to the National Center for Tumor Diseases (NCT), in Heidelberg, Germany.

NCT Heidelberg is a joint institution, uniting the German Cancer Research Center (DKFZ) and the Heidelberg University Hospital (UKHD), which combines excellent patient care with innovative cancer research under one roof; state-of-the-art research is to be translated as fast as possible into better treatment and prevention strategies. Professor Dr Andreas Schneeweiss, head of the Division of Gynecologic Oncology at NCT Heidelberg, commented: “This donation will support two innovative programs - CATCH and COGNITION - with the ultimate goal of implementing personalised therapy for breast cancer.”

Lydiane Saucède, Product Manager and Application Specialist at Integra, added: “We’re so pleased to have had this initiative running for four years. Since it’s humble beginning in 2015, we’ve been able to pledge over $35,000 to support cancer research institutes globally and advance research to fight breast cancer. We are excited to see how this latest donation will help to fund these groundbreaking programs.”

More information online